The R&D of ceramic biomaterials has extensively progressed in Japan since commercial production of calcium phosphates of hydroxyapatite and β-tricalcium phosphate, A-W glass, chemicals-and SBF (simulated body fluid)-treated metals, and yttria-stabilized zirconia for dental and medical applications. The centers of R&D excellence in Japan consist of universities and national research institutes in addition to industrial companies. The public organizations are listed below for reference. We, the members of Japanese strategic group for future ceramic biomaterials R&D, have discussed on the publication of our current research results for the worldwide R&D of ceramic biomaterials. In answer to our request, 5 leading organizations were willing to contribute to our action. The issue covers from syntheses of novel biomaterials of carbonated OCP (named as OCPC) and phosphate glass through the fundamental studies of ion releasing biological effects, protein adsorption mechanisms, and biological evaluation of hydroxyapatite to discovery of the nature of human bones. Especially, one of the guest 0959-2989/17/$35.00
